Training and resources for patients and consumers
The European Medicines Agency (EMA) provides support to patient and consumer representatives invited to participate in its activities as well as training sessions plus a collection of training videos and documents for anyone interested in learning more about EMA's activities.
The information helps interested patient and consumer representatives to understand:
- the work of EMA;
- the types of activities patients and consumers are involved in.
Training overview
EMA has published a training overview describing the activities and materials available to patients and consumers taking part in EMA activities and events. This overview takes into account feedback obtained from patient and consumer organisations:
Training overview for patients and consumers involved in EMA activities- Involvement of patient representatives in scientific advisory groups at EMA
- Involvement of patient representatives in scientific advice procedures at EMA
EMA Training Resources
EMA has developed a series of training videos targeted at patients and consumers entitled 'EMA basics'.
Together with the videos, EMA provides the presentation slides and related documents.
In-house training sessions
EMA holds an annual one-day training session for patients and consumers involved in EMA activities. The session offers an overview of medicines evaluation, with specific emphasis on when and how to get involved. Using a hands-on, interactive approach, participants learn about how they can contribute to scientific advice procedures, scientific-advisory-group meetings and reviewing information for patients.
For further information on previous annual training sessions, see:
- 2020 training session for patients, consumers and healthcare professionals (23/10/2020)
- 2017 training session for patients, consumers and healthcare professionals (21/11/2017)
- 2016 training session for patients and consumers (29/11/2016)
- 2015 training session for patients and consumers (25/11/2015)
- 2014 training session for patients and consumers (25/11/2014)
The video recording of the 2014 annual training session is available:
Workshops
For information on recent EMA workshops of particular relevance to patients and consumers, or where they have participated as speakers, see:
- Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party(HCPWP) joint workshop on personalised medicines (14/03/2017)
- Cystic Fibrosis Registry workshop(14/06/2017)
- Multiple Sclerosis Registry workshop (07/07/2017)
- Data anonymisation workshop (30/11/2017 - 01/12/2017)
- PCWP and HCPWP joint meeting: info session on antimicrobial resistance (19/09/2017)
- Workshop on site and histology - Independent indications in oncology (14-15/12/2017)
- Multi-stakeholder workshop to further improve the implementation of the Paediatric Regulation (20/03/2018)
- PCWP and HCPWP joint meeting: info session on antimicrobial resistance (19/09/2017)
- PCWP and HCPWP joint workshop on personalised medicines (14/03/2017)
- Public-private collaborations & partnerships for vaccine benefit-risk monitoring in Europe: the ADVANCE framework and governance principles (23-24/03/2017)
- 2017 annual workshop of the European network of paediatric research at the European Medicines Agency (Enpr-EMA) (16/05/2017)
- Eleventh stakeholder forum on the pharmacovigilance legislation (21/09/2017)
- EMA/DIA information day on measuring the impact of pharmacovigilance activities (14/11/2017)
- A common data model in Europe? – Why? Which? How? (11-12/12/2017)
- Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party(HCPWP) joint workshop on personalised medicines (14/03/2017)
External training initiatives
Members of EMA's eligible organisation also have training initatives that promote a better understanding of the development and approval of medicines as well as the involvement of patients and consumers in these processes. While EMA takes care in selecting external websites, it accepts no responsibility for the content:
- The European Patients' Academy (EUPATI) is a pan-European Innovative Medicines Initiative project of 33 organisations, led by the European Patients' Forum, with partners from patient organisations, universities and not-for-profit organisations, along with a number of European pharmaceutical companies. It provides scientifically reliable, objective and comprehensive information to patients on medicines research and development.
- The EURORDIS Summer School helps prepare patients for advocating for medicines development, equal access to treatments across Europe and ensuring that medical information is clear, accurate and comprehensible. EURORDIS launched this training programme for patient experts in 2008.
- The European Patient Ambassador Programme (EPAP) is a self-learning programme introducing patients and carers to the essential skills and knowledge needed to interact with healthcare professionals, policy-makers, researchers and journalists. The training programme was developed by the European Lung Foundation and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Leeds, York and Bradford, with the help of patients, and professionals with expertise in key areas.
Follow the journey of a medicine for human use assessed by EMA in this interactive timeline. It explains all stages from initial research to patient access, including how EMA supports medicine development, assesses the benefits and risks and monitors the safety of medicines.
The full text is available as a
booklet
.
